CVR number 37407976
Industry 21.2000 Manufacture of pharmaceutical preparations

Aquaporin Membrane Proteins ApS

 

Quicksearch
from your own companies
Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...
Bankruptcy Risk 
2013
N/A
2014
N/A
2015
N/A
2016
2016/12
2017
2017/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  0.0% 0.0% 0.0% 4.7% 21.3%  
Credit score (0-100)  0 0 0 48 6  
Credit rating  N/A N/A N/A BBB B  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  
How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2013
N/A
2014
N/A
2015
N/A
2016
2016/12
2017
2017/12
Net sales  0 0 0 0 0  
Gross profit  0.0 0.0 0.0 -4,424 0.0  
EBITDA  0.0 0.0 0.0 -1,201 0.0  
EBIT  0.0 0.0 0.0 -1,201 0.0  
Pre-tax profit (PTP)  0.0 0.0 0.0 -1,203.7 0.0  
Net earnings  0.0 0.0 0.0 -939.8 5,699.0  
Pre-tax profit without non-rec. items  0.0 0.0 0.0 -1,204 0.0  
 
See the entire income statement

Balance sheet (kDKK) 
2013
N/A
2014
N/A
2015
N/A
2016
2016/12
2017
2017/12
Tangible assets total  0.0 0.0 0.0 7,207 0.0  
Shareholders equity total  0.0 0.0 0.0 6,610 12,309  
Interest-bearing liabilities  0.0 0.0 0.0 430 1,239  
Balance sheet total (assets)  0.0 0.0 0.0 17,473 14,889  
Net Debt  0.0 0.0 0.0 -6,187 -13,650  
 
See the entire balance sheet

Volume 
2013
N/A
2014
N/A
2015
N/A
2016
2016/12
2017
2017/12
Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  0.0 0.0 0.0 -4,424 0.0  
Gross profit growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Employees  0 0 0 4 0  
Employee growth %  0.0% 0.0% 0.0% 0.0% -100.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  0 0 0 17,473 14,889  
Balance sheet change%  0.0% 0.0% 0.0% 0.0% -14.8%  
Added value  0.0 0.0 0.0 -1,200.8 0.0  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 0 0 7,207 -7,207  
Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  0.0 0.0 0.0 -1.0 0.0  

Profitability 
2013
N/A
2014
N/A
2015
N/A
2016
2016/12
2017
2017/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  0.0% 0.0% 0.0% 27.1% 0.0%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  0.0% 0.0% 0.0% -6.7% 0.0%  
ROI %  0.0% 0.0% 0.0% -16.6% 0.0%  
ROE %  0.0% 0.0% 0.0% -14.2% 60.2%  

Solidity 
2013
N/A
2014
N/A
2015
N/A
2016
2016/12
2017
2017/12
Equity ratio %  0.0% 0.0% 0.0% 49.1% 82.7%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  0.0% 0.0% 0.0% 515.2% 0.0%  
Gearing %  0.0% 0.0% 0.0% 6.5% 10.1%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 0.0% 17.7% 0.0%  

Liquidity 
2013
N/A
2014
N/A
2015
N/A
2016
2016/12
2017
2017/12
Quick Ratio  0.0 0.0 0.0 1.5 5.8  
Current Ratio  0.0 0.0 0.0 0.9 5.8  
Cash and cash equivalent  0.0 0.0 0.0 6,616.7 14,888.6  

Capital use efficiency 
2013
N/A
2014
N/A
2015
N/A
2016
2016/12
2017
2017/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  0.0 0.0 0.0 -878.0 12,309.2  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2013
N/A
2014
N/A
2015
N/A
2016
2016/12
2017
2017/12
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 0 -300 0  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 0 -300 0  
EBIT / employee  0 0 0 -300 0  
Net earnings / employee  0 0 0 -235 0